查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301122

緩釋輔料的市場規模、份額和趨勢分析報告：2023-2030 年按給藥途徑、技術、產品、地區和細分市場劃分的趨勢

Sustained Release Excipients Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Transdermal), By Technology (Transdermal, Implants), By Product (Gelatin, Sugars), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

緩釋輔料市場增長和趨勢

GrandView Research, Inc.最新報告顯示，2023年至2030年，全球緩釋輔料市場規模將以8.4%的複合年增長率擴張，2030年將達到23.6億美元。預計達到100萬美元。

緩釋輔料市場的增長歸因於緩釋藥物需求的增加、患者依從率的提高以及這種給藥方法相對於傳統方法的多重優勢。 這些賦形劑通常用作膠囊或片劑以提供藥物的緩慢釋放。 這縮短了藥物劑量之間的間隔，這比立即釋放製劑具有優勢。 賦形劑的崩解、溶解和降解導致藥物持續釋放。

控釋給藥系統的優點包括減少給藥頻率、提高患者依從性、恆定血漿藥物濃度、降低過量毒性發生率以及提高長期成本效益。這是使用控釋藥物遞送系統的一些主要優點 經常使用傳統口服藥物通常會導致不良症狀，例如胃腸道不適、痙攣、噁心和腹瀉。 緩釋藥物製劑的使用可以緩解患者的這些症狀，並使他們能夠維持體內所需的治療藥物水平。 此外，他們正在增加緩釋製劑的採用，從而提高患者的依從性並提高治療效果。

過去幾年，全球範圍內的抗生素耐藥性有所增加。 傳統製劑的濫用和誤用已被確定為抗生素耐藥性的主要原因。 在某些情況下，患者在給藥後幾天內康復並停止推薦劑量的藥物。 這種抵抗導致醫療費用增加、住院時間延長和死亡率增加。 傳染病和慢性病的增加也導致了抗生素耐藥性，這對傳統劑型市場產生了不利影響。 因此，正在引入替代方法來治療和控制這些疾病。

控釋製劑被醫生廣泛接受，用於預防抗生素耐藥性。 這些製劑在血漿中產生良好的治療藥物水平並降低給藥頻率，使其成為醫生的理想選擇，並增加了行業的需求。 由於 COVID-19 大流行，一些國家實施封鎖和運輸/旅行禁令，對藥品生產的干擾以及對輔料需求的影響將是相對短期的。 然而，各國長期封鎖導致的供應中斷可能會對固體口服藥物的生產產生重大影響。

這反過來將對全球輔料需求的增長產生重大影響。 歐洲，包括法國、西班牙和意大利，行業增長空間很大。 這是由於這些國家越來越多地採用先進藥物。 此外，歐洲藥品管理局（EMA）和藥品及保健品監管局（MHRA）等監管機構正在不斷努力，以確保該地區的高安全標準和易於獲得低成本藥品。 高可支配收入、先進的醫療基礎設施和不斷增加的產品批准預計將為歐洲創造增長機會。

市場主要參與者不斷推出新產品，以滿足製藥行業不斷變化的消費者需求。 例如，2022年11月，Roquette Freres宣布推出Pearitol CR-H，該產品增強了壓縮製劑中藥物的持續釋放。 該產品將進一步提升壓片工藝，提高競爭力。

緩釋輔料市場報告亮點

  • 聚合物產品細分市場將在 2022 年佔據最大份額 聚合物在緩釋製劑中的多樣化應用預計將推動行業增長
  • 傳統的口服給藥途徑促進了該細分市場的快速增長存儲、預給藥、便攜性和非侵入性等便利性是推動透皮給藥途徑採用的主要因素。
  • 透皮貼劑的日益普及促進了該細分市場的快速增長。
  • 由於許多行業參與者都擁有強大的產品組合，2022 年靶向給藥將佔銷售額的最大份額。 植入式緩釋藥物輸送系統具有效率高、副作用少、便利性高等優點，正在推動該領域的發展。
  • 由於在研發方面的高投入以及先進技術的可用性，北美將在 2022 年主導全球行業
  • 由於印度和中國等新興經濟體的製藥業不斷發展，亞太地區預計在預測期內將創下最快的複合年增長率。
  • 主要市場參與者包括 Roquette Freres、BASF、International Flavors & Fragrances, Inc.、Ashland、Evonik Industries AG、Croda International Plc 和 Gattefosse。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 段定義
  • 區域範圍
  • 估計/預測時間表
  • 目的
  • 調查方法
  • 信息獲取
    • 購買的數據庫
    • Gvr 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 型號詳細信息
    • 產品流分析
  • 輔助信息列表
  • 縮寫列表

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場體系展望
    • 母公司市場前景
    • 相關/輔助市場前景
  • 市場趨勢和展望
  • 市場動態
    • 與傳統劑型相比，益處更多
    • 兒童和老年人對緩釋劑型的需求
    • 抗生素耐藥性
  • 市場製約因素分析
    • 劑量傾卸引起的藥物毒性
    • 需要高劑量 API
  • 商業環境分析
    • SWOT 分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
  • COVID-19 感染的影響分析
  • 市場機遇與挑戰分析

第四章產品業務分析

  • 緩釋輔料市場：產品變異分析
  • 明膠
  • 聚合物
  • 礦物質
  • 糖
  • 酒精
  • 殼聚醣

第 5 章技術業務分析

  • 緩釋輔料市場：技術波動分析
  • 有針對性的交付
  • 微膠囊化
  • 沃斯特法
  • 透皮
  • 植入物
  • 凝聚
  • 其他

第 6 章管理途徑業務分析

  • 緩釋輔料市場：給藥途徑變化分析
  • 口頭
  • 肌肉注射
  • 皮下注射
  • 透皮
  • 陰道
  • 眼科
  • 靜脈注射
  • 其他

第七章區域業務分析

  • 2022 年和 2030 年按地區劃分的緩釋輔料市場份額
  • 北美
    • SWOT分析
    • 北美緩釋輔料市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 歐洲緩釋輔料市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 2018-2030 年亞太地區緩釋輔料市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲緩釋輔料市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 緩釋輔料市場，2018-2030 年
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 8 章競爭格局

  • 公司分類
  • 戰略規劃
    • 推出新產品
    • 合作夥伴關係
    • 獲取
    • 合作
    • 籌款
  • 2022 年主要參與者的市場份額分析
  • 公司簡介
    • BASF SE
    • International Flavors &Fragrances, Inc.
    • Ashland Global
    • Evonik Industries Inc
    • Croda International Plc
    • Gattefosse
    • Merck KGaA
Product Code: GVR-2-68038-575-5

Sustained Release Excipients Market Growth & Trends

The global sustained release excipients market size is expected to reach USD 2.36 billion by 2030, expanding at a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the sustained-release excipients market is attributable to the growing demand for sustained-release drugs, the improvement in patient compliance rate, and the multiple advantages of this drug-delivery method over conventional methods. These excipients are usually used as capsules and tablet formulations to release the drug slower; thereby, the drug has to be taken at less frequent intervals making it advantageous over immediate-release formulations. The sustained release of excipients' disintegration, dissolution, or degradation leads to the modified slower drug release.

Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using sustained release drug delivery systems. Regular consumption of oral conventional drugs generally results in undesired symptoms, such as gastrointestinal upset, cramps, nausea, and diarrhea. The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. Moreover, these have been increasing the adoption of sustained-release formulations, enabling higher patient compliance and improved therapeutic effect.

Over the past few years, there has been a global rise in antibiotic resistance. Overuse and misuse of conventional drug formulations have been identified as the major cause of antibiotic resistance. In some instances, patients recover within a few days of drug administration and discontinue the recommended dose of drugs, culminating in resistance. Such resistance leads to higher medical costs, longer hospital stays, and a rise in mortality rate. The rise in the incidence of infectious and chronic diseases has also resulted in antibiotic resistance, which has negatively impacted the conventional dosage forms market. Thus, alternative procedures to treat and manage these diseases are being implemented.

Controlled release formulations have been extensively accepted among physicians to prevent antibiotic resistance. Since these formulations generate preferred therapeutic drug levels in blood plasma and decrease the dosage frequency, they are an ideal choice among physicians, increasing their demand in the industry. The impact of disruptions on pharmaceutical production and subsequently on excipient demand affected by lockdowns and transport and travel bans across several countries due to the COVID-19 pandemic will be comparatively short-term. However, the supply disruptions due to extended lockdowns in different countries may substantially impact the oral solid dosage form drug manufacturing.

This, in turn, will significantly impact the excipients' demand growth globally. There is a wide scope for industry growth in Europe, including France, Spain, and Italy. This is due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines & Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs in this region. High disposable income, sophisticated healthcare infrastructure, and a rise in product approvals are expected to create growth opportunities in Europe.

Key players in the market are introducing new products to continuously meet the changing requirements of consumers in the pharmaceutical industry. For instance, in November 2022, Roquette Freres announced the launch of Pearlitol CR-H, enhancing API's sustained release in compression formulations. It further enhances the tableting process giving it a competitive edge.

Sustained Release Excipients Market Report Highlights

  • Polymers product segment accounted for the largest share in 2022. Varied usage of polymers in sustained-release formulations is anticipated to fuel industry growth
  • Conventional use of the oral delivery route has contributed to the fastest growth of the segment. Convenience, in terms of storage, premeasured doses, portability, and the noninvasive nature of this route are some of the major factors accelerating its adoption
  • The rising adoption of transdermal patches has contributed to the fastest growth of the segment
  • Targeted drug delivery constituted the largest revenue share in 2022, as a large number of industry players have strong product portfolios. Implantable sustained-release drug delivery systems have improved efficiency, lower adverse effects, and higher convenience, which impels segment growth
  • North America dominated the global industry in 2022 owing to the high investments in R&D and the availability of highly sophisticated technologies in the region
  • Asia Pacific is projected to register the fastest CAGR during the forecast period due to the growing pharmaceutical industry in emerging countries, such as India and China
  • A few of the key market players include Roquette Freres, BASF, International Flavors & Fragrances, Inc., Ashland, Evonik Industries AG, Croda International Plc, and Gattefosse

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Segment
      • 1.1.1.2 Technology Segment
      • 1.1.1.3 Route Of Administration Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increased benefits over conventional dosage forms
    • 3.4.2. Necessity of pediatric and geriatric sustained release dosage forms
    • 3.4.3. Antibiotic resistance
  • 3.5. Market Restraint Analysis
    • 3.5.1. Drug toxicity due to dose dumping
    • 3.5.2. Need for high dose of API
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis
  • 3.8. Market Opportubnity and Challenge Analysis

Chapter 4. Product Business Analysis

  • 4.1. Sustained Release Excipients Market: Product Movement Analysis
  • 4.2. Gelatin
    • 4.2.1. Gelatin Market, 2018 - 2030 (USD Million)
  • 4.3. Polymers
    • 4.3.1. Polymers Market, 2018 - 2030 (USD Million)
  • 4.4. Minerals
    • 4.4.1. Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Sugars
    • 4.5.1. Sugars Market, 2018 - 2030 (USD Million)
  • 4.6. Alcohols
    • 4.6.1. Alcohols Market, 2018 - 2030 (USD Million)
  • 4.7. Chitosan
    • 4.7.1. Chitosan Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Sustained Release Excipients Market: Technology Movement Analysis
    • 5.1.1. Targeted Delivery
  • 5.2. Targeted Delivery Market, 2018 - 2030 (USD Million)
    • 5.2.1. Micro Encapsulation
  • 5.3. Micro Encapsulation Market, 2018 - 2030 (USD Million)
    • 5.3.1. Wurster Technique
  • 5.4. Wurster Technique Market, 2018 - 2030 (USD Million)
    • 5.4.1. Transdermal
  • 5.5. Transdermal Market, 2018 - 2030 (USD Million)
    • 5.5.1. Implants
  • 5.6. Implants Market, 2018 - 2030 (USD Million)
    • 5.6.1. Coacervation
  • 5.7. Coacervation Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Sustained Release Excipients Market: Route of Administration Movement Analysis
  • 6.2. Oral
    • 6.2.1. Oral Market, 2018 - 2030 (USD Million)
  • 6.3. Intramuscular
    • 6.3.1. Intramuscular Market, 2018 - 2030 (USD Million)
  • 6.4. Subcutaneous
    • 6.4.1. Subcutaneous Market, 2018 - 2030 (USD Million)
  • 6.5. Transdermal
    • 6.5.1. Transdermal Market, 2018 - 2030 (USD Million)
  • 6.6. Vaginal
    • 6.6.1. Vaginal Market, 2018 - 2030 (USD Million)
  • 6.7. Ophthalmic
    • 6.7.1. Ophthalmic Market, 2018 - 2030 (USD Million)
  • 6.8. Intravenous
    • 6.8.1. Intravenous Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Sustained Release Excipients Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. UK Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. Thailand Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Sustained Release Excipients Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2022
  • 8.4. Company Profiles
    • 8.4.1. BASF SE
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. International Flavors & Fragrances, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Ashland Global
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Evonik Industries Inc
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Croda International Plc
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Gattefosse
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Merck KGaA
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 North America Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 Canada Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Europe Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Europe Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Europe Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 Germany Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Germany Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Germany Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 UK Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 UK Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 UK Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 France Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 France Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 France Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Italy Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Italy Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Italy Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Spain Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Spain Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Denmark Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Denmark Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 Sweden Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Sweden Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Sweden Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Norway Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Norway Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Norway Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 China Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 China Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 China Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 Japan Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 India Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 India Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 India Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 South Korea Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 South Korea Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Australia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Australia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Australia Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Thailand Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 66 Thailand Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 Thailand Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 70 Latin America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 Latin America Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Brazil Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Brazil Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Brazil Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 Mexico Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Mexico Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Mexico Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 79 Argentina Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 Argentina Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 South Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 South Africa Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 UAE Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 UAE Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 93 UAE Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Sustained Release Excipients Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Sustained Release Excipients Market: by Product Movement Analysis
  • Fig. 16 Global Sustained Release Excipients Market, for Gelatin, 2018 - 2030 (USD Million)
  • Fig. 17 Global Sustained Release Excipients Market, for Polymers, 2018 - 2030 (USD Million)
  • Fig. 18 Global Sustained Release Excipients Market, for Minerals, 2018 - 2030 (USD Million)
  • Fig. 19 Global Sustained Release Excipients Market, for Sugars, 2018 - 2030 (USD Million)
  • Fig. 20 Global Sustained Release Excipients Market, for Alcohol, 2018 - 2030 (USD Million)
  • Fig. 21 Global Sustained Release Excipients Market, for Chitosan, 2018 - 2030 (USD Million)
  • Fig. 22 Global Sustained Release Excipients Market: Technology Movement Analysis
  • Fig. 23 Global Sustained Release Excipients Market, for Targeted Delivery, 2018 - 2030 (USD Million)
  • Fig. 24 Global Sustained Release Excipients Market, for Micro Encapsulation, 2018 - 2030 (USD Million)
  • Fig. 25 Global Sustained Release Excipients Market, for Wurster Technique, 2018 - 2030 (USD Million)
  • Fig. 26 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
  • Fig. 27 Global Sustained Release Excipients Market, for Implants, 2018 - 2030 (USD Million)
  • Fig. 28 Global Sustained Release Excipients Market, for Coacervation, 2018 - 2030 (USD Million)
  • Fig. 29 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global Sustained Release Excipients Market: Route of Administration Movement Analysis
  • Fig. 31 Global Sustained Release Excipients Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 32 Global Sustained Release Excipients Market, for Intramuscular, 2018 - 2030 (USD Million)
  • Fig. 33 Global Sustained Release Excipients Market, for Subcutaneous, 2018 - 2030 (USD Million)
  • Fig. 34 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
  • Fig. 35 Global Sustained Release Excipients Market, for Vaginal, 2018 - 2030 (USD Million)
  • Fig. 36 Global Sustained Release Excipients Market, for Ophthalmic, 2018 - 2030 (USD Million)
  • Fig. 37 Global Sustained Release Excipients Market, for Intravenous, 2018 - 2030 (USD Million)
  • Fig. 38 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 39 Sustained Release Excipients Market :Regional Outlook, 2022 & 2030, 2018 - 2030 (USD Million)
  • Fig. 40 North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait Sustained Release Excipients Market, 2018 - 2030 (USD Million)